Advanced search
Publication Cover
Journal of Nutritional & Environmental Medicine Volume 12, 2002 - Issue 3
Journal homepage
7
Views
3
CrossRef citations to date
0
Altmetric
Research Article

A Multi-country Ecological Study of Dietary Risk and Risk-reduction Factors for Prostate Cancer

William B. Grant 12 Sir Francis Wyatt Place, Newport News, VA 23606–3660, USA [email protected]
Pages 187-196 | Published online: 13 Jul 2009

  • Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981 ; 66: 1191-308.
  • Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland, N Engl J Med 2000; 343: 78-85.
  • Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev 2001; 23: 72-81.
  • Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: S4-S66.
  • Grant WB. An ecologic study of dietary links to prostate cancer. Altern Med Rev 1999; 4: 162-9.
  • Chan JA, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 2001 ; 23: 87-92.
  • Fair WR, Fleshner NE, Heston W. Cancer of the prostate: a nutritional disease? Urology 1997; 50: 840-8.
  • Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002; 94: 391-8.
  • Bosetti C, Tzonou A, Lagiou P, Negri E, Trichopoulos D, Hsieh CC. Fraction of prostate cancer incidence attributed to diet in Athens, Greece. Eur J Cancer Prev 2000; 9: 119-23.
  • Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Cancer 1992; 70: 2861-9.
  • Feldman D, Zhao XY, Krishnan AV. Editorial/mini-review: Vitamin D and prostate cancer. Endocrinology 2000; 141: 5-9.
  • Luscombe CJ, Fryer AA, French ME et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 2001; 358: 641-2.
  • Potter JD. Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research, 1997.
  • Blumenfeld AJ, Fleshner N, Casselman B, Trachtenberg J. Nutritional aspects of prostate cancer: a review. Can J Urol 2000; 7: 927-35; discussion 936.
  • Chan JM, Giovannucci EL. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev 2001 ; 23: 82-6.
  • Schulman CC, Ekane S, Zlotta AR. Nutrition and prostate cancer: evidence or suspicion? Urology 2001; 58: 318-34.
  • Sesso HD, Paffenbarger RS Jr, Lee IM. Alcohol consumption and risk of prostate cancer: The Harvard Alumni Health Study. Int J Epidemiol 2001 ; 30: 749-55.
  • Sharpe CR, Siemiatycki J. Case-control study of alcohol consumption and prostate cancer risk in Montreal, Canada. Cancer Causes Control 2001; 12: 589-98.
  • Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer 1997; 76: 678-87.
  • Norrish AE, Skeaff CM, Arribas GL, Sharpe SJ, Jackson RT. Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer 1999; 81: 1238-42.
  • Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol Biomarkers Prev 1998; 7: 673-80.
  • Ganmaa D, Li XM, Wang J, Qin LQ, Wang PY, Sato A. Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int J Cancer 2002; 98: 262-7.
  • Kolonel LN, Hankin JH, Whittemore AS et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9: 795-804.
  • World Health Organization. World Health Statistics Annual, 1986-1990. Geneva: World Health Organization.
  • World Health Organization. Databank (http://www-depdb.iarc.fr/who/menu.htm). Accessed 1 June 2002.
  • Food and Agriculture Organization of the United Nations. Food Balance Sheets, Rome, Italy, 1991, 1996.
  • Grant WB. An ecologic study of dietary and solar UV-B links to breast cancer mortality rates. Cancer 2002; 94: 272-81.
  • Jacobs DR Jr, Marquait L, Slavin J, Kushi LH. Whole-grain intake and cancer: an expanded review and meta-analysis. Nutr Cancer 1998; 30: 85-96.
  • Talamini R, Franceschi S, LaVecchia C et al. Diet and prostatic cancer: case-control study in northern Italy. Nutr Cancer 1992; 48: 277-86.
  • Morton MS, Chan PS, Cheng C et al. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate 1997; 32: 122-8.
  • Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin Endocrine 1 Metab 1998; 12: 605-23.
  • Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention : timing and mechanisms of action in murine mammary and prostate. J Nutr 2002; 132: 552S-8S.
  • Slavin JL, Martini MC, Jacobs DR Jr, Marquait L. Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr 1999; 70(Suppl.): 459S-63S.
  • Bylund A, Zhang JX, Bergh A et al. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinom a in nude mice. Prostate 2000; 42: 304-14.
  • Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H. Identification of lignans as major components in the phenolic fraction of olive oil. Clin Chem 2000; 46: 976-88.
  • Denis L, Morton MS, Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol 1999; 35: 377-87.
  • Harper A, Kerr DJ, Gescher A, Chipman JK. Antioxidant effects of isoflavonoids and lignans, and protection against DNA oxidation. Free Radie Res 1999; 31: 149-60.
  • Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 2002; 20: 631-6.
  • Brooks JD, Paton VG, Vidanes G. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 2001; 10: 949-54.
  • Chiao JW, Chung F, Krzeminski J et al. Modulation of growth of human prostate cancer cells by the N-acetyIcysteine conjugate of phenethyl isothiocyanate. Int J Oncol 2000; 16: 1215-19.
  • McCarty MF. Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity. Med Hypotheses 1999; 53: 459-85.
  • Yeh JK, Aloia JF. Dietary constituents and somatomedin activity. Metabolism 1978; 27: 507-9.
  • Doi SQ, Rasaiah S, Tack I et al Low-protein diet suppresses serum insulin-like growth factor-1 and decelerates the progression of growth hormone-induced glomerulosclerosis. Am J Nephrol 2001; 21: 331-9.
  • Djavan B, Waldert M, Seitz C, Marberger M. Insulin-like growth factors and prostate cancer. World J Urol 2001; 19:225-33.
  • Shi R, Berkel HJ, Yu H. Insulin-like growth factor-1 and prostate cancer: a meta-analysis. Br J Cancer 2001:85:991-6.
  • Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 1999; 53: 83-7.
  • Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131:31098-208.
  • Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385-91.
  • Hsing AW, Chua S Jr, Gao YT et al Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001; 93: 783-9.
  • Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Increased serum insulin associated with increased risk of prostate cancer recurrence. Prostate 2002; 50: 1-3.
  • Gupta K, Krishnaswamy G, Kamad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci 2002; 323: 140-5.
  • Oyama N, Akino H, Suzuki Y et al. The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol 1999; 29: 623-9.
  • Kubota K. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001 ; 15: 471-86.
  • Gapstur SM, Gann PH, Colangelo LA et al. Postload plasma glucose concentration and 27-year prostate cancer mortality (United Slates). Cancer Causes Control 2001 ; 12: 763-72.
  • Devesa SS, Grauman DJ, Blot WJ, Pennello GA, Hoover RN, Fraumeni JF Jr. Atlas of Cancer Mortality in the United States, 1950-1994. NIH Publication no. 99-4564, 1999 (http://cancer.gov/atlasplus/new.html). Accessed 12 April 2002.
  • Ness J, Nassimiha D, Feria MI, Aronow WS. Diabetes mellitus in older African-Americans, Hispanics, and whites in an academic hospital-based geriatrics practice. Coron Artery Dis 1999; 10: 343-6.
  • Rosenberg DJ, Neugut AI, Ahsan H, Shea S. Diabetes mellitus and the risk of prostate cancer. Cancer Invest 2002; 20: 157-65.
  • Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol 1989; 129: 511-17.
  • Neugut AI, Rosenberg DJ, Ahsan H et al Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 1998; 7: 869-73.
  • Grant WB. Milk and other dietary influences on coronary heart disease. Altern Med Rev 1998; 3: 281-94.
  • Grant WB. An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002; 94: 1867-75.
  • van den Bernd GJ, Chang GT. Vitamin D and vitamin D analogs in cancer treatment. Curr Drug Targets 2002; 3: 85-94.
  • Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002; 59: 257-62.
  • Giovannucci E. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 1998; 9: 567-82.
  • Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci 1999; 8889: 107-19.
  • Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 1999; 39: 246-61.
  • Koeneman KS, Kao C, Ko SC et al Osteocalcin-directed gene therapy for prostate-cancer bone metastasis. World J Urol 2000; 18: 102-10.
  • Thalmann GN, Sikes RA, Devoll RE et al. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 1999; 5: 2271-7.
  • Fu Z, Dozmorov IM, Keller ET. Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. Prostate 2002; 51: 10-20.
  • Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM. Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrine 1 Metab 2001 ; 281 : E1267-74.
  • Tovar Sepulveda VA, Falzon M. Regulation of PTH-related protein gene expression by vitamin D in PC-3 prostate cancer cells. Mol Cell Endocrine 1 2002; 190: 115-24.
  • Dougherty KM, Blomme EA, Koh AJ et al. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res 1999; 59: 6015-22.
  • Tovar Sepulveda VA, Falzon M. Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways. Regul Pept 2002; 105: 109-20.
  • Gujral A, Burton DW, Terkeltaub R, Deftos LJ. Parathyroid hormone-related protein induces interleukin 8 production by prostate cancer cells via a novel intracrine mechanism not mediated by its classical nuclear localization sequence. Cancer Res 2001 ; 61: 2282-8.
  • Brawley OW, Barnes S, Parnes H. The future of prostate cancer prevention. Ann NY Acad Sci 2001; 952: 145-52.
  • Kushi LH, Cunningham JE, Hebert JR, Lerman RH, Bandera EV, Teas J. The macrobiotic diet in cancer. J Nutr 2001; 131(Suppl.): 3056S-64S.
  • Saxe GA, Hebert JR, Carmody JF et al. Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? J Urol 2001 ; 166: 2202-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.